Myomo (MYO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Myomo faces a critical inflection point as its reliance on lumpy insurance authorizations drives volatile revenue growth, which decelerated to 2.9% in 2026Q1. Despite maintaining gross margins near 68.2%, the company has failed to achieve operating leverage, with SG&A expenses consistently outpacing gross profit.
Price trend, volume and key moving averages
Trailing total returns as of 11/19/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 9, 2026 | -$0.07+10.3% vs -$0.08 | $12M+7.1% vs $12M |
Q3 2026 Aug 5, 2026 | -$0.07+28.6% vs -$0.10 | $12M+13.1% vs $10M |
Q2 2026 May 7, 2026 | -$0.09+25.0% vs -$0.12 | $10M+9.5% vs $9M |
Q2 2026 Mar 9, 2026 | -$0.08+11.1% vs -$0.09 | $11M+9.1% vs $10M |
Myomo (MYO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Myomo NYSEAMERICAN: MYO reported record third-quarter revenue of $12.3 million, up 22% from a year earlier, and narrowed its full-year revenue guidance as referrals and higher sales of its powered arm braces helped improve operating performance.
Myomo, Inc. (MYO) Q3 2026 Earnings Call Transcript
Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.09 per share a year ago.
Benchmark MYO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Myomo, Inc. (MYO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.88 | $34M | -2.54 | 25.73% | -33.14% | -208.07% | — | |
| $6.08 | $1.62B | -30.17 | 18.96% | -43.56% | -28.22% | — | |
| $7.06 | $1.09B | -12.79 | 24.95% | -10.35% | -547.17% | — | |
| $3.59 | $247.17M | -5.11 | -38.1% | -41.73% | -15.17% | — | |
| $70.53 | $9.51B | 17.20 | 16.65% | 17.76% | 11.82% | — | |
| $10.73 | $1.24B | -10.29 | 8.28% | -16.78% | -35.81% | — |
Myomo, Inc. (MYO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Myomo, Inc. (MYO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 9, 2026·SEC
Aug 5, 2026·SEC
Jun 26, 2026·SEC
Get notified when MYO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Myomo, Inc. (MYO) stock FAQ — growth, dividends, profitability & financials explained
Myomo, Inc. (MYO) reported $45.5M in revenue over the trailing twelve months. Revenue was $40.9M in fiscal year 2025. That is 4382% more than the $0.9M of fiscal year 2014.
Myomo, Inc. (MYO) grew revenue by 9.3% over the trailing twelve months, compared with the twelve months before.
No. Myomo, Inc. (MYO) reported a net loss of $15.1M over the trailing twelve months.
Myomo, Inc. (MYO) had a return on equity (ROE) of -208.1% over the trailing twelve months. A negative ROE means the company lost money over the period.
Myomo, Inc. (MYO) had negative free cash flow of $7.7M over the trailing twelve months.